Diabetes in Texas: Growing Severity of Problem, Higher Cost of Care than National Average
A new report from The Texas Business Group on Health (TBGH) shows that when it comes to the use of evidence-based medical care for Type 2 diabetes patients, such as A1c tests, cholesterol tests and eye exams, Texas continues to rank lower than the national averages. This report includes information for key local markets across the state including Austin, Dallas, El Paso, Fort Worth/Arlington, Houston and San Antonio. Also included are state and national benchmarks that can help providers and employers identify better opportunities to serve the needs of their patients and employees.
In 2008, the number of patients diagnosed with Type 2 diabetes rose sharply across Texas, perhaps suggesting a worsening epidemic, but also greater awareness of diabetes risks and more aggressive diagnosing. The highest increase in prevalence was in El Paso, where 74 percent more individuals were diagnosed with Type 2 diabetes in 2008 than the year before. Other communities that also had relatively large increases in prevalence include Houston (41percent); Austin (34 percent); and Dallas (31 percent).
The cost of treating commercially insured Type 2 diabetes patients in Texas hospitals in 2008, regardless of setting (inpatient, outpatient, emergency room), exceeded the national averages. In fact, inpatient charges were 20 percent higher than the national average of $52,730, and an 11 percent increase over Texas hospitals’ 2007 inpatient charges of $56,765 per Type 2 diabetes patient. Houston had the highest hospital inpatient charges for Type 2 diabetes patients at $62,816 per patient, which is a 13 percent increase over the year before. The lowest cost market was Ft. Worth/Arlington, where Type 2 diabetes inpatient charges were $52,243, which is a surprising 10 percent drop from the year before (2007).
To learn more about this research, please visit:
http://www.dfwbgh.org/documents/PR_9-14-09.pdf
>>Return to this week's disease management news